B-CELL MARKERS EXPRESSION IS AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Moura, R. A. [1 ]
Quaresma, C. [1 ]
Vieira, A. R. [1 ]
Goncalves, M. J. [1 ,2 ]
Polido-Pereira, J. [1 ,2 ]
Romao, V. [1 ,2 ]
Martins, N. [2 ]
Canhao, H. [1 ,2 ]
Fonseca, J. E. [1 ,2 ]
机构：
[1] Hosp Santa Maria, EPE, Lisbon Acad Med Ctr, Ctr Hosp Lisboa Norte,Rheumatol Res Unit,Inst Med, Lisbon, Portugal
[2] Hosp Santa Maria, EPE, Lisbon Acad Med Ctr, Ctr Hosp Lisboa Norte,Rheumatol Dept, Lisbon, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0024
引用
收藏
页码：905 / 905
页数：1
相关论文
共 50 条
  • [1] B-CELL MARKERS EXPRESSION IS AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, R. A.
    Quaresma, C.
    Vieira, A. R.
    Goncalves, M. J.
    Polido-Pereira, J.
    Romao, V.
    Martins, N.
    Canhao, H.
    Fonseca, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A5 - A5
  • [2] B-CELL PHENOTYPE AND IGD-CD27-MEMORY B CELLS ARE AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, Rita A.
    Quaresma, Claudia
    Vieira, Ana R.
    Goncalves, Maria J.
    Polido-Pereira, Joaquim
    Romao, Vasco C.
    Martins, Nadia
    Canhao, Helena
    Fonseca, Joao E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A3 - A3
  • [3] B-cell phenotype and IgD-CD27-memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis
    Moura, Rita A.
    Quaresma, Claudia
    Vieira, Ana R.
    Goncalves, Maria J.
    Polido-Pereira, Joaquim
    Romao, Vasco C.
    Martins, Nadia
    Canhao, Helena
    Fonseca, Joao E.
    PLOS ONE, 2017, 12 (09):
  • [4] B-CELL PHENOTYPE AND IGD-CD27-MEMORY B CELLS ARE AFFECTED BY TNF-INHIBITORS AND TOCILIZUMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Moura, R. A.
    Quaresma, C.
    Vieira, A. R.
    Goncalves, M. J.
    Polido-Pereira, J.
    Romao, V. C.
    Martins, N.
    Canhao, H.
    Fonesca, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 834 - 834
  • [5] Treatment of rheumatoid Arthritis in Practice - a Comparison of Tocilizumab vs. TNF-Inhibitors (CONSENS)
    Backhaus, M.
    Kaufmann, J.
    Richter, C.
    Vollmer, M.
    Volberg, C.
    Wassenberg, S.
    Roske, A.
    Hellmann, P.
    Gaubitz, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 119 - 120
  • [6] Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
    Tanaka, Yoshiya
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (03) : 319 - 326
  • [7] A cost-efficacy comparison of TNF-inhibitors in the treatment of rheumatoid arthritis
    Chiou, C
    Malone, DC
    Wanke, LA
    Yu, EB
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 269 - 269
  • [8] THE INFLUENCE OF RITUXIMAB AND TOCILIZUMAB TREATMENT ON B-CELL SUBSETS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Suponitskaya, E.
    Aleksankin, A.
    Avdeeva, A.
    Aleksandrova, E.
    Novikov, A.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 498 - 498
  • [9] The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
    Ingrid Lekander
    Fredrik Borgström
    Jörgen Lysholm
    Ronald F. van Vollenhoven
    Staffan Lindblad
    Pierre Geborek
    Gisela Kobelt
    The European Journal of Health Economics, 2013, 14 : 863 - 873
  • [10] The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
    Lekander, Ingrid
    Borgstrom, Fredrik
    Lysholm, Jorgen
    van Vollenhoven, Ronald F.
    Lindblad, Staffan
    Geborek, Pierre
    Kobelt, Gisela
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (06): : 863 - 873
12345